Henry Schein, Inc. (NASDAQ:HSIC) Given Consensus Rating of "Moderate Buy" by Brokerages

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) has been given a consensus rating of "Moderate Buy" by the eleven analysts that are presently covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $81.10.

Several brokerages recently issued reports on HSIC. Barrington Research reaffirmed an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a research report on Wednesday, February 26th. Wells Fargo & Company initiated coverage on Henry Schein in a research note on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective on the stock. StockNews.com downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Jefferies Financial Group boosted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Finally, Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and increased their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th.

Henry Schein Trading Up 1.5 %

Shares of NASDAQ:HSIC traded up $0.98 during midday trading on Monday, hitting $65.52. 899,376 shares of the stock were exchanged, compared to its average volume of 1,610,911. The business's 50-day moving average price is $69.87 and its 200 day moving average price is $71.88. Henry Schein has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock has a market capitalization of $8.03 billion, a price-to-earnings ratio of 26.96, a P/E/G ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company's revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.66 earnings per share. Analysts predict that Henry Schein will post 4.74 earnings per share for the current year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Institutional Trading of Henry Schein

Several hedge funds have recently bought and sold shares of HSIC. Versant Capital Management Inc lifted its stake in shares of Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after buying an additional 335 shares in the last quarter. Investment Management Corp VA ADV acquired a new stake in shares of Henry Schein in the 4th quarter worth about $32,000. Rakuten Securities Inc. bought a new position in Henry Schein in the 1st quarter valued at about $34,000. Venturi Wealth Management LLC boosted its stake in Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after purchasing an additional 569 shares during the last quarter. Finally, Quent Capital LLC boosted its stake in Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after purchasing an additional 323 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.